Halozyme Therapeutics shares owned by Empower Advisory Group
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Empower Advisory Group
from 13F filings
Historical chart of Empower Advisory Group investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Empower Advisory Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Empower Advisory Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $301k | 4.1k | 73.34 |
| 2025-06-30 | $232k | 4.5k | 52.02 |
| 2025-03-31 | $284k | 4.5k | 63.81 |
| 2024-12-31 | $273k | 5.7k | 47.81 |
| 2024-09-30 | $327k | 5.7k | 57.24 |
| 2024-06-30 | $307k | 5.9k | 52.36 |
| 2024-03-31 | $239k | 5.9k | 40.68 |
| 2023-12-31 | $273k | 7.4k | 36.96 |
| 2023-09-30 | $282k | 7.4k | 38.20 |
| 2023-06-30 | $266k | 7.4k | 36.07 |
| 2023-03-31 | $286k | 7.4k | 38.74 |